BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 962526)

  • 21. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (4).--Anti-inflammatory activity of N-5' (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):473-81. PubMed ID: 700512
    [No Abstract]   [Full Text] [Related]  

  • 22. Action of some substituted anthranilic acids on Escherichia coli.
    VOLCANI BE; SICHER S; BERGMANN ED; BENDAS H
    J Biol Chem; 1954 Mar; 207(1):411-20. PubMed ID: 13152117
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the metabolism of N-(3-chloro-2-methylphenyl)anthranilic acid (GEA 6414), a new anti-inflammatory agent. I. Urinary metabolites of GEA 6414 in human, dogs, rabbits and rats (author's transl)].
    Kuninaka T; Sugai K; Saito T; Mori N; Kimura R; Murata T
    Yakugaku Zasshi; 1981 Mar; 101(3):232-8. PubMed ID: 7299634
    [No Abstract]   [Full Text] [Related]  

  • 24. Experiments in relief of clinical pain with N-(2,3-xylyl)-anthranilic acid (CI-473; mefenamic acid).
    CASS LJ; FREDERIK WS
    J Pharmacol Exp Ther; 1963 Feb; 139():172-6. PubMed ID: 14019111
    [No Abstract]   [Full Text] [Related]  

  • 25. [NON-STEROID, ANTI-INFLAMMATORY SUBSTANCES. II. N-(FLUOROPHENYL) ANTHRANILIC ACIDS].
    DELBARRE F; BUU HOUI NP; KAHAN A; JACQUIGNON P; BROUILHET H; MARTY M; PERIN F
    Med Exp Int J Exp Med; 1964; 11():389-96. PubMed ID: 14250121
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (5).--Influence of N-5' on the histamine release from peritoneal exudate cells (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):483-90. PubMed ID: 81163
    [No Abstract]   [Full Text] [Related]  

  • 27. Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists.
    Varnavas A; Lassiani L; Valenta V; Berti F; Mennuni L; Makovec F
    Bioorg Med Chem; 2003 Mar; 11(5):741-51. PubMed ID: 12538004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the syntheses of analgesics. LII. Synthesis of 4a-(3-substituted phenyl)-1,2-disubstituted decahydrocinnoline derivatives (studies on the syntheses of heterocyclic compounds. DCCCXLIII) (author's transl)].
    Kametani T; Kigasawa K; Hiiragi M; Ishimaru H; Wagatsuma N; Kohagizawa T; Nakamura T
    Yakugaku Zasshi; 1980 Jun; 100(6):641-8. PubMed ID: 7463311
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reaction of furfural with methyl anthranilate and methyl 2-aminonicotinate (author's transl)].
    Reisch J; Mahran MR
    Arch Pharm (Weinheim); 1977 Mar; 310(3):259-63. PubMed ID: 851387
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on chemical structure and analgetic activity of phenyl substituted aminomethylcyclohexanoles (author's transl)].
    Flick K; Frankus E; Friderichs E
    Arzneimittelforschung; 1978; 28(1a):107-13. PubMed ID: 580207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New quinoline derivatives: synthesis and evaluation for antiinflammatory and analgesic properties--Note II.
    Savini L; Massarelli P; Pellerano C; Bruni G
    Farmaco; 1993 Jun; 48(6):805-25. PubMed ID: 8373505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the syntheses of analgesics. LV. Synthesis of 4a-(3-substituted phenyl)1,2-disubstituted decahydrocinnoline derivatives (2) (studies on the syntheses of heterocyclic compounds. CMLV) (author's transl)].
    Kametani T; Kigasawa K; Hiiragi M; Wagatsuma N; Kohagizawa T; Uryu T; Nakamura T
    Yakugaku Zasshi; 1982 Jan; 102(2):173-81. PubMed ID: 7108748
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: Structure optimization of N-acylanthranilic acid derivatives.
    Yamaoka N; Murano K; Kodama H; Maeda A; Dan T; Nakabayashi T; Miyata T; Meguro K
    Bioorg Med Chem Lett; 2018 Feb; 28(4):809-813. PubMed ID: 29366646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory and antipyretic properties of N-(alpha,alpha,alpha-trifluoro-m-tolyl) anthranilic acid (CI-440; flufenamic acid).
    WINDER CV; WAX J; SERRANO B; JONES EM; McPHEE ML
    Arthritis Rheum; 1963 Feb; 6():36-47. PubMed ID: 14001133
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfoximine directed intermolecular o-C-H amidation of arenes with sulfonyl azides.
    Yadav MR; Rit RK; Sahoo AK
    Org Lett; 2013 Apr; 15(7):1638-41. PubMed ID: 23477353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALPHA- AND GAMMA-GLUTAMYL DERIVATIVES OF AMINOBENZOIC ACIDS.
    LLOYD RF; SKINNER CG; SHIVE W
    J Med Chem; 1965 May; 8():398-400. PubMed ID: 14323161
    [No Abstract]   [Full Text] [Related]  

  • 37. [Linkage of anthranilic and metanilic acid salts of diazonium to pyrazolones].
    Stefănescu E; Gheorghită N; Pavelescu M; Pĭsaroc-Doru G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):313-5. PubMed ID: 3911321
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid).
    WINDER CV; WAX J; SCOTTI L; SCHERRER RA; JONES EM; SHORT FW
    J Pharmacol Exp Ther; 1962 Dec; 138():405-13. PubMed ID: 14001132
    [No Abstract]   [Full Text] [Related]  

  • 39. ISCHEMIC ARM PAIN AND THE NONNARCOTIC ANALGESIC MEFENAMIC ACID, N-(2,3-XYLYL)ANTHRANILIC ACID.
    WILLIAMS MW; WILLIAMS CS; KARTCHNER MJ
    Toxicol Appl Pharmacol; 1965 Jan; 7():45-52. PubMed ID: 14256602
    [No Abstract]   [Full Text] [Related]  

  • 40. [The mechanism of the reaction of anthranil amide with lactones (author's transl)].
    Möhrle H; Seidel CM
    Arch Pharm (Weinheim); 1976 Jul; 309(7):542-50. PubMed ID: 1021033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.